YARW
Yarrow Bioscience Inc
YARW | NASDAQ
$19.90
-$0.10 (-0.50%)
At close: Oct 30, 2026, 4:00 PM ET
$19.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-0.50%
(1D)No price chart data available for 1D timeframe.
Rating
40.5
+12.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #526/1028 (Top 51%)
Key Statistics
Market Data
Market Cap $185.16M
1D Range
19.28 20.61
52W Range
18.31 42.94
Valuation (TTM)
PE -0.85
PB 8.39
EV/EBITDA -8.61
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $5.75
Cash Flow
FCF Yield -9.2%
SBC Adj. FCF Yield -9.9%
SBC Impact -8.8%
Margins
Gross Margin 97.5%
Operating Margin -4134.6%
FCF Margin -3513.1%
Growth (CAGR)
Revenue 3Y | 5Y 5.8% |
-43.1%
Dil EPS 3Y | 5Y 80.0% |
67.1%
FCF 3Y | 5Y 17.6% |
13.6%
Returns
ROA -79.3%
ROE -70.2%
ROIC -90.3%
Financial Health
Net Cash
$22.93M
Current Ratio 15.26
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential...
Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Jul 28, 2026
Website www.yarrowbioscience.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove YARW